Evaluating the efficacy of upadacitinib in patients with moderate rheumatoid arthritis: a post-hoc analysis of the SELECT phase 3 trials

Conaghan, P.G. orcid.org/0000-0002-3478-5665, Pavelka, K., Hsieh, S.-C. et al. (4 more authors) (2023) Evaluating the efficacy of upadacitinib in patients with moderate rheumatoid arthritis: a post-hoc analysis of the SELECT phase 3 trials. Rheumatology Advances in Practice, 7 (1). rkad017. ISSN 2514-1775

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© The Author(s) 2023. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License (CC-BY-NC 4.0) which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.

Keywords: RA; moderate; moderate disease activity; upadacitinib; JAK inhibitors
Dates:
  • Published: 8 February 2023
  • Published (online): 8 February 2023
  • Accepted: 18 November 2022
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Musculoskeletal Medicine & Imaging (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 08 Dec 2023 10:33
Last Modified: 08 Dec 2023 10:33
Status: Published
Publisher: Oxford University Press
Identification Number: 10.1093/rap/rkad017
Related URLs:
Open Archives Initiative ID (OAI ID):

Download

Export

Statistics